SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-146652
Filing Date
2012-04-03
Accepted
2012-04-02 20:52:32
Documents
3
Period of Report
2012-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d326793d8k.htm 8-K 22775
2 PRESS RELEASE d326793dex991.htm EX-99.1 17621
3 GRAPHIC g326793g72q75.jpg GRAPHIC 8703
  Complete submission text file 0001193125-12-146652.txt   53868
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 12735184
SIC: 2834 Pharmaceutical Preparations